Guidelines for the Compilation of a Product Dossier for Submission in the Assessment Procedure for New and Multi-Source (Generic) Products Used in the Treatment of Malaria
(11 pages)
Índice de contenido
Ver el documentoSection 1. Details of the product
Ver el documentoSection 2. Regulatory situation in other countries
Abrir esta carpeta y ver su contenidoSection 3. Active pharmaceutical ingredient (s) (API)
Cerrar esta carpetaSection 4. Finished product
Ver el documentoSection 4.1 Formulation
Ver el documentoSection 4.2. Sites of manufacture
Ver el documentoSection 4.3 Manufacturing procedure
Ver el documentoSection 4.4 Specifications for excipients
Ver el documentoSection 4.5 Specifications for the finished product
Ver el documentoSection 4.6 Container/closure system(s) and other packaging
Ver el documentoSection 4.7 Stability testing
Ver el documentoSection 4.8 Container labelling
Ver el documentoSection 4.9 Product information
Ver el documentoSection 4.10 Patient information and package inserts
Ver el documentoSection 4.11 Justification for any differences to the product in the country or countries issuing the submitted WHO-type certificate(s)6
Abrir esta carpeta y ver su contenidoSection 5. Efficacy and safety
 

Section 4.2. Sites of manufacture

State the name and street address of each facility where any aspect of manufacture occurs, including production, sterilization, packaging and quality control. Indicate the activity performed at each site.

Include any alternative manufacturers.

For each site where the major production step(s) is/are carried out, attach a certificate issued by the competent authority in terms of the WHO Certification Scheme on the Quality of Pharmaceutical Products Moving in International Commerce. Include the product information approved by that authority with, if available, the summary basis of approval (or similar) and any other relevant material.

Ir a la sección anterior Ir a la siguiente sección
 

Última actualización: le 3 mayo 2013